Literature DB >> 30239376

The ROMA trial: why it is needed.

Mario F L Gaudino1, David P Taggart2, Stephen E Fremes3.   

Abstract

PURPOSE OF REVIEW: We herein summarize the current evidence on the clinical outcome associated with the use of single and multiple arterial grafts for coronary bypass surgery and the role and importance of the Randomized comparison of the clinical Outcome of single versus Multiple Arterial grafts (ROMA) trial. RECENT
FINDINGS: Observational evidence suggests that the use of multiple arterial grafts is associated with better clinical outcomes compared to the use of a single arterial graft. Randomized evidence is inconclusive; the 5-year interim analysis of the largest randomized trial on the topic did not show any clinical benefit associated with the use of bilateral versus single internal thoracic arteries, whereas a pooled analysis of the trials comparing the radial artery and the saphenous vein as a second graft showed a significant reduction in follow-up cardiac events using the radial artery. Hidden confounders and treatment allocation biases as well as methodological flaws are the most likely explanation of this contradiction.
SUMMARY: ROMA was conceived based on the lessons learned from a critical analysis of the existing randomized and observational evidence with the aim to provide a definitive answer to the question of the potential clinical benefit of multiple arterial grafts for coronary bypass.

Mesh:

Year:  2018        PMID: 30239376     DOI: 10.1097/HCO.0000000000000565

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  5 in total

1.  Secondary prevention after coronary artery bypass grafting: Anticoagulation and antiplatelet therapy is only one factor.

Authors:  Frank W Sellke
Journal:  J Card Surg       Date:  2021-01-28       Impact factor: 1.620

Review 2.  Coronary Artery Bypass: Review of Surgical Techniques and Impact on Long-Term Revascularization Outcomes.

Authors:  Brian McNichols; John R Spratt; Jerin George; Scott Rizzi; Eddie W Manning; Ki Park
Journal:  Cardiol Ther       Date:  2021-01-30

3.  Cost-effectiveness of bilateral vs. single internal thoracic artery grafts at 10 years.

Authors:  Matthew Little; Alastair M Gray; Douglas G Altman; Umberto Benedetto; Marcus Flather; Stephen Gerry; Belinda Lees; Jacqueline Murphy; Mario Gaudino; David P Taggart
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2022-05-05

4.  Long-term survival of single versus bilateral internal mammary artery grafting in patients under 70.

Authors:  Armando Abreu; José Máximo; Adelino Leite-Moreira
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-09-09

Review 5.  Is the Use of BIMA in CABG Sub-Optimal? A Review of the Current Clinical and Economic Evidence Including Innovative Approaches to the Management of Mediastinitis.

Authors:  Nicolai Bayer; Warren Mark Hart; Tan Arulampalam; Colette Hamilton; Michael Schmoeckel
Journal:  Ann Thorac Cardiovasc Surg       Date:  2020-09-14       Impact factor: 1.520

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.